Motivational interviewing for smoking cessation.
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
31 07 2019
31 07 2019
Historique:
aheadofprint:
31
07
2019
entrez:
20
8
2019
pubmed:
20
8
2019
medline:
20
8
2019
Statut:
epublish
Résumé
Motivational Interviewing (MI) is a directive patient-centred style of counselling, designed to help people to explore and resolve ambivalence about behaviour change. It was developed as a treatment for alcohol abuse, but may help people to a make a successful attempt to stop smoking. To evaluate the efficacy of MI for smoking cessation compared with no treatment, in addition to another form of smoking cessation treatment, and compared with other types of smoking cessation treatment. We also investigated whether more intensive MI is more effective than less intensive MI for smoking cessation. We searched the Cochrane Tobacco Addiction Group Specialised Register for studies using the term motivat* NEAR2 (interview* OR enhanc* OR session* OR counsel* OR practi* OR behav*) in the title or abstract, or motivation* as a keyword. We also searched trial registries to identify unpublished studies. Date of the most recent search: August 2018. Randomised controlled trials in which MI or its variants were offered to smokers to assist smoking cessation. We excluded trials that did not assess cessation as an outcome, with follow-up less than six months, and with additional non-MI intervention components not matched between arms. We excluded trials in pregnant women as these are covered elsewhere. We followed standard Cochrane methods. Smoking cessation was measured after at least six months, using the most rigorous definition available, on an intention-to-treat basis. We calculated risk ratios (RR) and 95% confidence intervals (CI) for smoking cessation for each study, where possible. We grouped eligible studies according to the type of comparison. We carried out meta-analyses where appropriate, using Mantel-Haenszel random-effects models. We extracted data on mental health outcomes and quality of life and summarised these narratively. We identified 37 eligible studies involving over 15,000 participants who smoked tobacco. The majority of studies recruited participants with particular characteristics, often from groups of people who are less likely to seek support to stop smoking than the general population. Although a few studies recruited participants who intended to stop smoking soon or had no intentions to quit, most recruited a population without regard to their intention to quit. MI was conducted in one to 12 sessions, with the total duration of MI ranging from five to 315 minutes across studies. We judged four of the 37 studies to be at low risk of bias, and 11 to be at high risk, but restricting the analysis only to those studies at low or unclear risk did not significantly alter results, apart from in one case - our analysis comparing higher to lower intensity MI.We found low-certainty evidence, limited by risk of bias and imprecision, comparing the effect of MI to no treatment for smoking cessation (RR = 0.84, 95% CI 0.63 to 1.12; I There is insufficient evidence to show whether or not MI helps people to stop smoking compared with no intervention, as an addition to other types of behavioural support for smoking cessation, or compared with other types of behavioural support for smoking cessation. It is also unclear whether more intensive MI is more effective than less intensive MI. All estimates of treatment effect were of low certainty because of concerns about bias in the trials, imprecision and inconsistency. Consequently, future trials are likely to change these conclusions. There is almost no evidence on whether MI for smoking cessation improves mental well-being.
Sections du résumé
BACKGROUND
Motivational Interviewing (MI) is a directive patient-centred style of counselling, designed to help people to explore and resolve ambivalence about behaviour change. It was developed as a treatment for alcohol abuse, but may help people to a make a successful attempt to stop smoking.
OBJECTIVES
To evaluate the efficacy of MI for smoking cessation compared with no treatment, in addition to another form of smoking cessation treatment, and compared with other types of smoking cessation treatment. We also investigated whether more intensive MI is more effective than less intensive MI for smoking cessation.
SEARCH METHODS
We searched the Cochrane Tobacco Addiction Group Specialised Register for studies using the term motivat* NEAR2 (interview* OR enhanc* OR session* OR counsel* OR practi* OR behav*) in the title or abstract, or motivation* as a keyword. We also searched trial registries to identify unpublished studies. Date of the most recent search: August 2018.
SELECTION CRITERIA
Randomised controlled trials in which MI or its variants were offered to smokers to assist smoking cessation. We excluded trials that did not assess cessation as an outcome, with follow-up less than six months, and with additional non-MI intervention components not matched between arms. We excluded trials in pregnant women as these are covered elsewhere.
DATA COLLECTION AND ANALYSIS
We followed standard Cochrane methods. Smoking cessation was measured after at least six months, using the most rigorous definition available, on an intention-to-treat basis. We calculated risk ratios (RR) and 95% confidence intervals (CI) for smoking cessation for each study, where possible. We grouped eligible studies according to the type of comparison. We carried out meta-analyses where appropriate, using Mantel-Haenszel random-effects models. We extracted data on mental health outcomes and quality of life and summarised these narratively.
MAIN RESULTS
We identified 37 eligible studies involving over 15,000 participants who smoked tobacco. The majority of studies recruited participants with particular characteristics, often from groups of people who are less likely to seek support to stop smoking than the general population. Although a few studies recruited participants who intended to stop smoking soon or had no intentions to quit, most recruited a population without regard to their intention to quit. MI was conducted in one to 12 sessions, with the total duration of MI ranging from five to 315 minutes across studies. We judged four of the 37 studies to be at low risk of bias, and 11 to be at high risk, but restricting the analysis only to those studies at low or unclear risk did not significantly alter results, apart from in one case - our analysis comparing higher to lower intensity MI.We found low-certainty evidence, limited by risk of bias and imprecision, comparing the effect of MI to no treatment for smoking cessation (RR = 0.84, 95% CI 0.63 to 1.12; I
AUTHORS' CONCLUSIONS
There is insufficient evidence to show whether or not MI helps people to stop smoking compared with no intervention, as an addition to other types of behavioural support for smoking cessation, or compared with other types of behavioural support for smoking cessation. It is also unclear whether more intensive MI is more effective than less intensive MI. All estimates of treatment effect were of low certainty because of concerns about bias in the trials, imprecision and inconsistency. Consequently, future trials are likely to change these conclusions. There is almost no evidence on whether MI for smoking cessation improves mental well-being.
Identifiants
pubmed: 31425622
doi: 10.1002/14651858.CD006936.pub4
pmc: PMC6699669
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD006936Subventions
Organisme : Department of Health
ID : SRP/16/114/20
Pays : United Kingdom
Références
BMJ. 2005 Aug 13;331(7513):373-7
pubmed: 16096304
Am J Health Promot. 2017 Mar;31(2):136-142
pubmed: 26559720
Prev Med. 2018 Jul;112:38-44
pubmed: 29626552
Cochrane Database Syst Rev. 2016 Jul 18;7:CD007025
pubmed: 27426026
Am J Health Promot. 2013 Jan-Feb;27(3):181-90
pubmed: 23286595
Nicotine Tob Res. 2013 May;15(5):932-41
pubmed: 23080378
Am J Prev Med. 2016 Oct;51(4):566-77
pubmed: 27647057
Nicotine Tob Res. 2016 Jul;18(7):1665-9
pubmed: 26834052
J Exp Ther Oncol. 2017 May;12(1):43-49
pubmed: 28472563
Am J Respir Crit Care Med. 2014 Jun 15;189(12):1530-7
pubmed: 24821270
Tob Control. 2019 Jan;28(1):88-94
pubmed: 29886411
Prev Chronic Dis. 2007 Jan;4(1):A08
pubmed: 17173716
J Korean Acad Nurs. 2015 Jun;45(3):347-56
pubmed: 26159136
Sci Rep. 2017 Nov 13;7(1):15473
pubmed: 29133798
Am J Crit Care. 2008 May;17(3):205-16
pubmed: 18476313
Addict Behav. 2012 Jul;37(7):817-23
pubmed: 22472523
Tob Control. 2003 Dec;12 Suppl 4:IV3-10
pubmed: 14645934
Drug Alcohol Depend. 2017 Jun 1;175:227-231
pubmed: 28458075
J Subst Abuse Treat. 2015 Aug;55:29-38
pubmed: 25805668
Addiction. 2016 Jan;111(1):117-28
pubmed: 26582140
J Int Soc Prev Community Dent. 2014 Dec;4(Suppl 2):S110-5
pubmed: 25558450
Am J Prev Med. 2016 Apr;50(4):518-527
pubmed: 26711163
Prev Med. 2010 Nov;51(5):387-93
pubmed: 20828584
J Gen Intern Med. 2005 Oct;20(10):889-94
pubmed: 16191133
J Clin Psychol. 2016 Mar;72(3):194-206
pubmed: 26783736
J Addict Dis. 2013;32(4):377-86
pubmed: 24325771
Nicotine Tob Res. 2016 Mar;18(3):243-50
pubmed: 25744954
Pediatrics. 2001 Jul;108(1):18-24
pubmed: 11433049
Addict Behav. 2015 Jan;40:66-72
pubmed: 25222850
Gen Hosp Psychiatry. 2010 Nov-Dec;32(6):599-606
pubmed: 21112451
Nicotine Tob Res. 2009 Jun;11(6):730-8
pubmed: 19395686
Contemp Clin Trials. 2014 May;38(1):113-20
pubmed: 24721481
J Gen Intern Med. 2006 Jun;21(6):590-5
pubmed: 16808741
Health Psychol. 2011 Nov;30(6):736-45
pubmed: 21859215
Addiction. 2009 Nov;104(11):1891-900
pubmed: 19719796
Ann Intern Med. 2009 Apr 7;150(7):437-46
pubmed: 19349629
Contemp Clin Trials. 2015 Jul;43:93-9
pubmed: 25962891
Nicotine Tob Res. 2009 Dec;11(12):1448-57
pubmed: 19915080
BMC Public Health. 2012 Aug 25;12:696
pubmed: 22920991
Diabetes Educ. 2006 Jul-Aug;32(4):562-70
pubmed: 16873594
Prev Med. 2004 Jan;38(1):10-9
pubmed: 14672637
J Consult Clin Psychol. 2017 Nov;85(11):1019-1028
pubmed: 29083219
Arch Intern Med. 2009 Nov 9;169(20):1928-30
pubmed: 19901150
Nicotine Tob Res. 2009 Aug;11(8):961-8
pubmed: 19553282
Nicotine Tob Res. 2007 Oct;9(10):1043-51
pubmed: 17943620
J Ethn Subst Abuse. 2013;12(4):374-90
pubmed: 24215228
Am J Prev Med. 2016 May;50(5):573-583
pubmed: 26711164
Nicotine Tob Res. 2005 Dec;7(6):881-9
pubmed: 16298723
Nicotine Tob Res. 2014 Apr;16(4):413-22
pubmed: 24174612
Addict Behav. 2002 Mar-Apr;27(2):275-92
pubmed: 11817768
Subst Use Misuse. 2016 Aug 23;51(10):1393-7
pubmed: 27267588
Nicotine Tob Res. 2009 Jun;11(6):739-49
pubmed: 19443788
BMC Cancer. 2018 Apr 2;18(1):364
pubmed: 29609554
BMC Public Health. 2012 Jun 19;12:456
pubmed: 22713093
Health Educ Res. 2000 Aug;15(4):491-502
pubmed: 11066466
Pediatrics. 2011 Jul;128(1):e101-11
pubmed: 21690120
Nicotine Tob Res. 2015 Sep;17(9):1104-11
pubmed: 25301816
Am J Health Promot. 2007 Jan-Feb;21(3):183-91
pubmed: 17233236
Patient Educ Couns. 2015 Aug;98(8):984-90
pubmed: 25766731
Psychol Addict Behav. 2014 Sep;28(3):743-51
pubmed: 25222173
Am J Drug Alcohol Abuse. 2002 Nov;28(4):671-9
pubmed: 12492263
Arch Pediatr Adolesc Med. 2003 Mar;157(3):295-302
pubmed: 12622686
Addiction. 2017 Jan;112(1):146-155
pubmed: 27566993
Addict Behav. 2009 Oct;34(10):887-91
pubmed: 19342179
J Consult Clin Psychol. 2010 Dec;78(6):868-84
pubmed: 21114344
JAMA Intern Med. 2015 Feb;175(2):218-26
pubmed: 25506771
Nicotine Tob Res. 2011 Mar;13(3):215-20
pubmed: 21233256
Psychiatry Res. 2007 Mar 30;150(2):141-52
pubmed: 17289155
Health Qual Life Outcomes. 2003 Oct 23;1:60
pubmed: 14613562
Am J Respir Crit Care Med. 2014 Jun 15;189(12):1457-8
pubmed: 24930527
Addict Behav. 2013 Jul;38(7):2321-4
pubmed: 23584193
J Adolesc Health. 2011 Oct;49(4):371-8
pubmed: 21939867
Contemp Clin Trials. 2015 Mar;41:298-312
pubmed: 25657051
Am J Psychiatry. 2000 Nov;157(11):1835-42
pubmed: 11058482
Contemp Clin Trials. 2018 Mar;66:1-8
pubmed: 29287665
Cochrane Database Syst Rev. 2016 May 05;(5):CD005336
pubmed: 27149547
Addiction. 2013 Jun;108(6):1136-44
pubmed: 23510102
Arch Intern Med. 1997 Dec 8-22;157(22):2653-60
pubmed: 9531235
Nicotine Tob Res. 2007 Dec;9(12):1297-307
pubmed: 18058348
Nicotine Tob Res. 2010 Nov;12(11):1118-24
pubmed: 20855414
Health Promot Pract. 2010 Sep;11(5):751-9
pubmed: 19116416
J Health Psychol. 2012 Jul;17(5):640-52
pubmed: 22076554
Cochrane Database Syst Rev. 2015 Jun 03;(6):CD011398
pubmed: 26037617
Cochrane Database Syst Rev. 2018 Dec 05;12:CD009269
pubmed: 30521696
Arch Intern Med. 2007 Jun 11;167(11):1152-8
pubmed: 17563023
JAMA Intern Med. 2019 Feb 1;179(2):167-174
pubmed: 30556832
Prev Med. 1998 Mar-Apr;27(2):296-303
pubmed: 9579010
J Consult Clin Psychol. 2004 Jun;72(3):371-81
pubmed: 15279521
Nicotine Tob Res. 2018 Nov 15;20(12):1434-1441
pubmed: 29145626
Arch Intern Med. 1989 Jul;149(7):1653-6
pubmed: 2742440
Prev Med. 1998 Sep-Oct;27(5 Pt 3):A39-46
pubmed: 9808816
J Fam Med. 2016;3(7):
pubmed: 28580456
Addict Behav. 2007 Oct;32(10):2404-10
pubmed: 17428617
Addict Behav. 2015 Jun;45:57-62
pubmed: 25644588
J Behav Med. 2015 Jun;38(3):472-82
pubmed: 25655663
Cochrane Database Syst Rev. 2017 Feb 14;2:CD001055
pubmed: 28196405
BMJ Open. 2016 Sep 20;6(9):e011520
pubmed: 27650761
Contemp Clin Trials. 2018 May;68:14-22
pubmed: 29549007
Ethn Dis. 1998 Autumn;8(3):385-93
pubmed: 9926909
Obstet Gynecol. 2006 Jul;108(1):83-92
pubmed: 16816060
Lancet. 2016 Oct 8;388(10053):1659-1724
pubmed: 27733284
Addict Behav. 2015 Apr;43:18-24
pubmed: 25531536
Ann Intern Med. 2002 Mar 19;136(6):429-37
pubmed: 11900495
Nicotine Tob Res. 2007 May;9(5):581-9
pubmed: 17454714
Prev Med. 2005 Mar;40(3):249-58
pubmed: 15533536
J Subst Abuse Treat. 2007 Jan;32(1):11-7
pubmed: 17175394
J Korean Acad Nurs. 2012 Feb;42(1):19-27
pubmed: 22410598
Am J Public Health. 2002 Feb;92(2):274-9
pubmed: 11818305
Nicotine Tob Res. 2017 Aug 01;19(8):916-921
pubmed: 28182218
Nicotine Tob Res. 2010 Apr;12(4):326-35
pubmed: 20154055
Prev Med. 1999 Jan;28(1):51-60
pubmed: 9973588
Br J Gen Pract. 2006 Oct;56(531):768-74
pubmed: 17007707
Am J Prev Med. 1999 Oct;17(3):161-8
pubmed: 10987630
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
Prev Med. 2000 Apr;30(4):261-8
pubmed: 10731452
Behav Cogn Psychother. 2009 Mar;37(2):129-40
pubmed: 19364414
Nicotine Tob Res. 2013 Jan;15(1):22-8
pubmed: 22589422
BMC Med Res Methodol. 2018 Jun 13;18(1):52
pubmed: 29895280
BMC Public Health. 2011 Sep 26;11:732
pubmed: 21943207
Addiction. 2006 Jun;101(6):883-91
pubmed: 16696632
Nicotine Tob Res. 2002 Feb;4(1):127-31
pubmed: 11906689
Addict Behav. 2007 Sep;32(9):1769-86
pubmed: 17250972
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
Patient Educ Couns. 2004 May;53(2):147-55
pubmed: 15140454
Addiction. 2007 Dec;102(12):1979-86
pubmed: 17916223
Am J Psychiatry. 2007 May;164(5):827-8; author reply 828
pubmed: 17475744
Nicotine Tob Res. 2008 Oct;10(10):1523-31
pubmed: 18946771
AIDS Educ Prev. 2009 Jun;21(3 Suppl):65-80
pubmed: 19537955
Cochrane Database Syst Rev. 2012 Nov 14;11:CD008937
pubmed: 23152266
Health Psychol Rev. 2015;9(2):205-23
pubmed: 26209209
Prev Med. 2005 Nov-Dec;41(5-6):815-21
pubmed: 16182355
Alcohol Clin Exp Res. 2002 Dec;26(12):1950-1
pubmed: 12500132
Trials. 2012 Aug 01;13:126
pubmed: 22852878
Health Educ Behav. 2012 Apr;39(2):191-7
pubmed: 22330092
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009748
pubmed: 22972147
Addiction. 2014 Nov;109(11):1942-52
pubmed: 24962451
BMC Public Health. 2011 Nov 11;11:859
pubmed: 22078490
Am J Public Health. 2000 May;90(5):786-9
pubmed: 10800431
J Subst Abuse Treat. 2014 Mar;46(3):346-55
pubmed: 24210533
Addiction. 2016 Jul;111(7):1257-66
pubmed: 26748541
Addict Behav. 2005 Jun;30(5):865-74
pubmed: 15893085
Cochrane Database Syst Rev. 2010 Nov 10;(11):CD004492
pubmed: 21069681
BMC Med Res Methodol. 2012 Jul 07;12:95
pubmed: 22770436
Nicotine Tob Res. 2007 Mar;9(3):421-8
pubmed: 17365774
J Consult Clin Psychol. 2001 Jun;69(3):429-39
pubmed: 11495172
Value Health. 2014 Nov;17(7):A779
pubmed: 27202885
Health Psychol Open. 2017 Oct 28;4(2):2055102917736429
pubmed: 29379624
Patient Educ Couns. 2011 Apr;83(1):129-33
pubmed: 20627440
Addict Behav. 2013 Aug;38(8):2402-8
pubmed: 23639851
Am J Addict. 2013 Jun 26;23(1):84-89
pubmed: 23898867
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Prev Med. 2014 Dec;69:126-31
pubmed: 25278424
Cochrane Database Syst Rev. 2015 Mar 02;(3):CD006936
pubmed: 25726920
Am J Health Behav. 2013 Jul;37(4):517-24
pubmed: 23985232
Am J Psychiatry. 2006 Nov;163(11):1934-42
pubmed: 17074945
Addict Behav. 2017 Dec;75:145-151
pubmed: 28734154
Nurs Res. 2004 Nov-Dec;53(6):396-405
pubmed: 15586136
Aust N Z J Psychiatry. 2017 Apr;51(4):366-381
pubmed: 28195010
Ann Epidemiol. 2002 Apr;12(3):206-12
pubmed: 11897179
Scand J Prim Health Care. 2006 Jun;24(2):75-80
pubmed: 16690554
Addiction. 2006 Apr;101(4):599-607
pubmed: 16548939
Tob Control. 2010 Oct;19(5):410-6
pubmed: 20675688
Prev Chronic Dis. 2017 Feb 23;14:E19
pubmed: 28231041
Addiction. 2005 Apr;100(4):470-8
pubmed: 15784061
Addiction. 2015 Oct;110(10):1676-83
pubmed: 26053958
Addiction. 2014 May;109(5):830-41
pubmed: 24428461
Prev Med. 2006 Dec;43(6):466-71
pubmed: 16920183
Tob Control. 2007 Dec;16 Suppl 1:i53-9
pubmed: 18048633
Clin Trials. 2011 Dec;8(6):744-54
pubmed: 22167112
Trials. 2014 Jul 05;15:266
pubmed: 24996596
Cochrane Database Syst Rev. 2011 May 11;(5):CD008063
pubmed: 21563163
Nicotine Tob Res. 2014 Mar;16(3):369-72
pubmed: 24158227
Addiction. 2016 Sep;111(9):1646-55
pubmed: 27184343
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006936
pubmed: 20091612
BMC Health Serv Res. 2015 Feb 01;15:46
pubmed: 25638351
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
BMC Public Health. 2013 Oct 31;13:1031
pubmed: 24172187
Health Educ Res. 2002 Oct;17(5):659-69
pubmed: 12408210